Innoviva, Inc. (NASDAQ:INVA)

About the company

Innoviva, Inc. is engaged in the development, commercialization, and financial management of bio-pharmaceuticals. Its portfolio includes Relvar Breo Ellipta, which is a once-daily combination medicine consisting of a long-acting beta2 agonist, vilanterol, and an inhaled corticosteroid, fluticasone furoate; and Anoro Ellipta, a once-daily medicine combining a long-acting muscarinic antagonist, umeclidinium bromide, LABA, VI. The company was founded by P. Roy Vagelos, Mathai Mammen, and George M. Whitesides in November 1996 and is headquartered in Burlingame, CA.

Sector

Health Technology

Industry

Pharmaceuticals: Other

Employees

6

CEO

Pavel Raifeld

Exchange

NASDAQ

Website

http://www.inva.com

$285.00M

Total Revenue

6

Employees

$2B

Market Capitalization

8.18

Price/Earning ratio

Stock price

Gross Margin (in %)

Total gross margin

$285M

Operating Margin (in %)

Total operating margin

$271M

Net Margin (in %)

Total net margin

$189M

Dividend Yield (in %)

Dividend per share

$0.75

Industry peers

Name Ticker Market capitalization (in USD Million) Revenues (in USD Million) Price/Book Price/Earning Net margin (in %)
Horizon Therapeutics Plc HZNP 11600.40 1376.00 4.95 18.29 43.06
Catalent, Inc. CTLT 10838.26 2872.00 5.44 103.91 3.63
Perrigo Co. Plc PRGO 7561.03 4837.00 1.30 51.58 3.02
Bausch Health Cos., Inc. BHC 6474.02 8597.00 9.03 -3.42 -21.96
Jazz Pharmaceuticals Plc JAZZ 6255.75 2188.00 2.16 22.86 12.81
United Therapeutics Corp. UTHR 5174.19 1443.00 1.80 9.99 36.59
MyoKardia, Inc. MYOK 4329.06 34.00 12.58 -13.96 -201.73
Axsome Therapeutics, Inc. AXSM 2833.95 None 19.23 -31.51 None
ArQule, Inc. ARQL 2240.00 5.00 15.75 -55.56 -808.06
SAGE Therapeutics, Inc. SAGE 2236.52 9.00 2.63 -3.45 -413.06
Pacira Biosciences, Inc. PCRX 2199.54 435.00 5.90 -5237.00 -0.02
Corcept Therapeutics, Inc. CORT 2095.96 335.00 4.81 19.75 31.64
Prestige Consumer Healthcare, Inc. PBH 1844.67 963.00 1.55 13.01 14.77
Revolution Medicines, Inc. RVMD 1829.59 48.00 4.75 -25.84 -146.29
Madrigal Pharmaceuticals, Inc. MDGL 1673.70 0.00 4.47 -16.38 -624.74
Ironwood Pharmaceuticals, Inc. IRWD 1598.26 440.00 -22.62 18.85 19.14
Innoviva, Inc. INVA 1580.87 285.00 3.74 8.18 66.41
Intercept Pharmaceuticals, Inc. ICPT 1506.88 272.00 -44.85 -4.39 -127.53
Portola Pharmaceuticals, Inc. PTLA 1329.78 121.00 19.53 -4.77 -232.73
Zogenix, Inc. ZGNX 1313.55 5.00 3.59 -3.09 -241.62
Supernus Pharmaceuticals, Inc. SUPN 1274.94 402.00 2.02 10.93 28.90
Revance Therapeutics, Inc. RVNC 1181.11 0.00 4.66 -6.33 41.82
Theravance Biopharma, Inc. TBPH 1169.64 88.00 -8.21 -4.74 -280.80
Amphastar Pharmaceuticals, Inc. AMPH 1074.08 327.00 2.68 21.08 15.90
Endo International Plc ENDP 795.72 3014.00 -1.09 -2.84 -9.09
BellRing Brands, Inc. BRBR 766.74 954.00 -0.42 5.82 13.98
Eagle Pharmaceuticals, Inc. EGRX 678.44 192.00 3.65 269.22 1.29
Assembly Biosciences, Inc. ASMB 672.22 16.00 3.01 -6.76 -601.75
Aerie Pharmaceuticals, Inc. AERI 642.62 79.00 5.10 -3.18 -252.92
Collegium Pharmaceutical, Inc. COLL 593.64 299.00 4.25 -45.95 -4.21
Anika Therapeutics, Inc. ANIK 537.18 125.00 1.86 19.38 22.73
Catalyst Pharmaceuticals, Inc. CPRX 514.67 119.00 5.01 11.73 36.09
Intersect ENT, Inc. XENT 439.36 102.00 4.15 -8.80 -48.61
BioDelivery Sciences International, Inc. BDSI 408.48 130.00 5.84 -55.50 -5.01
ANI Pharmaceuticals, Inc. ANIP 370.68 203.00 1.90 -237.62 -0.67
Albireo Pharma, Inc. ALBO 337.35 11.00 3.43 -4.41 -730.55
MEI Pharma, Inc. MEIP 289.67 5.00 4.99 -7.43 -539.48
Mallinckrodt Plc MNK 204.12 3037.00 0.11 -0.17 -39.56
Agile Therapeutics, Inc. AGRX 166.97 None 2.72 -8.09 None
Marinus Pharmaceuticals, Inc. MRNS 160.02 0.00 6.20 -2.37 None
Zynerba Pharmaceuticals, Inc. ZYNE 144.90 0.00 2.38 -4.04 -699.94
Cerecor, Inc. CERC 118.22 7.00 7.56 -5.24 -429.22
Ampio Pharmaceuticals, Inc. AMPE 94.38 1.00 66.00 -5.08 None
AcelRx Pharmaceuticals, Inc. ACRX 91.20 2.00 -1.68 -1.63 -644.25
Evoke Pharma, Inc. EVOK 89.28 None 31.00 -13.29 None
Adamas Pharmaceuticals, Inc. ADMS 71.68 57.00 -4.57 -0.77 -160.44
CTI BioPharma Corp. CTIC 69.62 3.00 3.11 -1.69 -111.83
Oramed Pharmaceuticals, Inc. ORMP 63.36 3.00 5.10 -4.96 -464.15
Aclaris Therapeutics, Inc. ACRS 61.50 4.00 1.08 -0.45 None
Cassava Sciences, Inc. SAVA 54.34 41.00 2.86 -11.92 76.71
SCYNEXIS, Inc. SCYX 48.89 0.00 10.27 -1.26 -30.84
Cumberland Pharmaceuticals, Inc. CPIX 48.60 47.00 0.99 -10.80 -9.59
Natural Alternatives International, Inc. NAII 48.58 114.00 0.67 -12.85 -3.19
Lipocine, Inc. LPCN 39.30 0.00 9.36 -2.62 None
IsoRay, Inc. ISR 37.52 9.00 7.00 -11.20 -36.08
Acasti Pharma, Inc. ACST 35.84 827.00 2.33 -0.58 -7.45
Neos Therapeutics, Inc. NEOS 34.45 65.00 -2.65 -1.97 -26.74
PLx Pharma, Inc. PLXP 27.99 0.00 -2.68 -2.96 119.04
CytRx Corp. CYTR 22.11 0.00 1.60 -3.19 408.46
EyeGate Pharmaceuticals, Inc. EYEG 19.00 3.00 2.36 -1.60 -264.21
Regulus Therapeutics, Inc. RGLS 14.49 0.00 1.28 -0.68 -272.13
Tetraphase Pharmaceuticals, Inc. TTPH 12.30 8.00 0.65 -0.15 -798.18
Intec Pharma Ltd. NTEC 10.43 None 1.34 -0.24 None
VIVUS, Inc. VVUS 8.69 73.00 -0.19 -0.29 -39.28
Sonoma Pharmaceuticals, Inc. SNOA 6.74 19.00 1.07 -2.16 -25.58
KemPharm, Inc. KMPH 6.02 15.00 -0.17 -0.35 -120.48
Hepion Pharmaceuticals, Inc. HEPA 5.68 None 1.77 -0.48 None
Tonix Pharmaceuticals Holding Corp. TNXP 4.20 None 1.05 -0.09 None
Ritter Pharmaceuticals, Inc. RTTR 0.45 None 0.17 -0.03 None

Latest insider transactions

Date Role Name Transaction Quantity Quantity Owned After

Here is What Hedge Funds Think About Innoviva, Inc. (INVA)

11d ago, source: YAHOO!

The latest 13F reporting period has come and gone, and Insider Monkey is again at the forefront when it comes to making use ...

Theravance Biopharma Appoints Deepika R. Pakianathan, Ph.D. to Board of Directors

3d ago, source: PR Newswire

PRNewswire/ -- Theravance Biopharma, Inc. (NASDAQ: TBPH) ("Theravance Biopharma" or the "Company"), a diversified ...

Noteworthy Monday Option Activity: INVA, BYND, STAA

13d ago, source: Nasdaq

Looking at options trading activity among components of the Russell 3000 index, there is noteworthy activity today in ...

Innoviva Inc (NASDAQ:INVA) Shares Sold by Balyasny Asset Management LLC

12d ago, source: theenterpriseleader.com

Balyasny Asset Management LLC decreased its position in shares of Innoviva Inc (NASDAQ:INVA) by 2.7% in the first quarter, ...

Theravance Biopharma Appoints Deepika R. Pakianathan, Ph.D. to Board of Directors

3d ago, source: WFMZ-TV

We have an economic interest in potential future payments from Glaxo Group Limited or one of its affiliates (GSK) pursuant to its agreements with Innoviva, Inc. relating to certain programs ...

Theravance Biopharma Appoints Deepika R. Pakianathan, Ph.D. to Board of Directors

3d ago, source: Business Insider

© 2020 Insider Inc. and finanzen.net GmbH All rights reserved. Registration on or use of this site constitutes acceptance of our Terms of Service and Privacy Policy ...



Portfolio items

Follow companies to create your optimal portfolio.
or
Refresh this page to see your newly added stocks.